Received Jan 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUN4 | INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) | MEDIMMUNE VACCINES, INC. | UNK | yh3387 | IN / NS |
Pt administered a frozen flumist; Would be inefficacious and not sure what affect on body; A spontaneous report has been received from a pharmacist. The report concerns a female adolescent patient born in 2014. No medical history was reported. No concomitant products were reported. The patient received Flumist Quadrivalent (batch number(s) yh3387) (expiration date(s) 08-Dec-2025) .1 milliliter, via nasal use for to prevent flu on 05-Nov-2025. The patient received 1 dose(s). The report described a medication error for Flumist Quadrivalent. On 05-Nov-2025, the patient experienced pt administered a frozen flumist (Preferred term: Product preparation error). The report described lack of effect for Flumist Quadrivalent. The reported term was would be inefficacious and not sure what affect on body (Preferred term: Drug ineffective). The dose of Flumist Quadrivalent (flumist, influenza virus vaccine polyvalent, q/laiv) was not changed. The patient recovered from the event(s) pt administered a frozen flumist and would be inefficacious and not sure what affect on body after 1 day on 05-Nov-2025. The events were considered non-serious. Device Information: Combination Product Report: Yes Product As Reported: Flumist Quadrivalent Brand Name: FLUMIST QUADRIVALENT Product Role:Suspect Device Problem code:A24 - Adverse Event Without Identified Device or Use Problem Manufacturer Name:ASTRAZENECA Labeled for single use:No
Medical History/Concurrent Conditions: Flu prevention